Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  American Journal of Cardiology

• Publication date

  1983-02-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(83)80200-8PMID 6338686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Five-year findings of the Hypertension Detection and Follow-up Program

  2005cited by this paper
• Open Assessment of the Effect of Prazosin on Plasma Lipids

  1982cited by this paper
• Should Mild Hypertension Be Treated?

  1982cited by this paper
• Sounding board. Should mild hypertension be treated?

  1982cited by this paper
• Plasma Lipid and Lipoprotein Changes in Hypertensive Patients Treated with Propranolol and Prazosin

  1982cited by this paper
• The Biochemical Effects of Antihypertensive Agents and the Impact on Atherosclerosis

  1982cited by this paper
• Effect of Prazosin on Serum Lipids

  1982cited by this paper
• A long-term prevention study with oxprenolol in coronary heart disease.

  1982cited by this paper
• Effect of Prazosin on Lipoprotein Metabolism in Premenopausal, Hypertensive Women

  1982cited by this paper
• Improvement of Glucose Tolerance and Lowering of Glycohemoglobin and Serum Lipid Concentrations After Discontinuation of Antihypertensive Drug Therapy

  1982cited by this paper
• Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

  1981cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Effect of propranolol and prazosin on blood lipids. The Oslo Study.

  1980cited by this paper
• EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS: The Oslo Study

  1980cited by this paper
• Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

  1980cited by this paper
• Glucosylation of human collagen in aging and diabetes mellitus.

  1980cited by this paper
• The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

  1980cited by this paper
• FAILURE OF THERAPY TO IMPROVE PROGNOSIS IN ELDERLY MALES WITH HYPERTENSION

  1980cited by this paper
• Nonenzymatic Glucosylation of Serum Proteins in Diabetes Mellitus

  1979cited by this paper
• Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

  1979cited by this paper
• Long-term effect of sotalol on plasma lipids.

  1979cited by this paper
• Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

  1979cited by this paper
• Coronary heart-disease after treatment of hypertension.

  1978cited by this paper
• Treatment of mild hypertension: results of a ten-year intervention trial.

  1977cited by this paper
• Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

  1977cited by this paper
• Alterations in Canine Myocardial Excitability during Ischemia

  1977cited by this paper
• ONE-DRUG REGIMENS FOR EPILEPSY

  1976cited by this paper
• Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study.

  1976cited by this paper
• Antihypertensive treatment and the course of established cerebral vascular disease.

  1973cited by this paper
• Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

  1972cited by this paper
• Premature mortality from coronary heart disease. The Framingham study.

  1971cited by this paper
• Carbohydrate metabolism during treatment with chlorthalidone and ethacrynic acid.

  1968cited by this paper
• Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

  1967cited by this paper
• Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.

  1966cited by this paper
• THIAZIDE- AND PHTHALIMIDINE-INDUCED HYPERGLYCEMIA IN HYPERTENSIVE PATIENTS.

  1965cited by this paper
• FRACTURE OF THE FEMORAL NECK.

  1964cited by this paper
• Further Observations Concerning the Hyperglycemic Activity of Benzothiadiazines

  1964cited by this paper

• Phase I Trials on Anti-hypertensive Drugs

  2020cites this paper
• Hyperlipidemia Associations with Hypertension Medications

  2020cites this paper
• Diuretics in patients with metabolic disturbances

  2018cites this paper
• Inhibition of angiotensin converting enzyme, human LDL cholesterol and DNA oxidation by hydrolysates from blacktip shark gelatin

  2013cites this paper
• Effects on Insulin Action of Adding Low-Dose Thiazide to Angiotensin-Converting Enzyme Inhibitor in Essential Hypertension

  2013cites this paper
• Effects of Ketanserin Tartrate on Serum Lipids in Patients with Essential Hypertension

  2012cites this paper
• The potential role of milk-derived peptides in cardiovascular disease.

  2011cites this paper
• Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.

  2009cites this paper
• Reduction of nonfatal reinfarctions in patients with a history of hypertension by chronic postinfarction treatment with metoprolol.

  2009cites this paper
• The Effects of γ-Aminobutyric Acid, Vinegar, and Dried Bonito on Blood Pressure in Normotensive and Mildly or Moderately Hypertensive Volunteers

  2009cites this paper
• Antihypertensive and antimicrobial bioactive peptides from milk proteins

  2008cites this paper
• ACE inhibitory peptides.

  2006cites this paper
• Drug-induced diabetes mellitus

  2005cites this paper
• A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive

  2005cites this paper
• Effects of carvedilol on serum lipids in hypertensive and normotensive subjects

  2005cites this paper
• Anti-hypertensive activity of fermented dairy products containing biogenic peptides

  2004cites this paper
• Hypotensive peptides from milk proteins.

  2004cites this paper
• Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension

  2004cites this paper
• The Emerging Role of Dairy Proteins and Bioactive Peptides in Nutrition and Health Hypotensive Peptides from Milk Proteins 1,2

  2004cites this paper
• 23 – Health-related functional value of dairy proteins and peptides

  2004cites this paper
• [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].

  2004cites this paper
• Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients

  2004cites this paper
• Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: A double-blind comparison with a combination of hydrochlorothiazide and amiloride

  2004cites this paper
• Anti-hypertensive activity of fermented dairy products containing biogenic peptides.

  2002cites this paper
• Clinical Effects of Brown Seaweed, Undaria pinnatifida (wakame), on Blood Pressure in Hypertensive Subjects

  2001cites this paper
• Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme

  2000cites this paper
• Captopril does not improve insulin action in essential hypertension: A double‐blind placebo‐controlled study

  1998cites this paper
• Is Cigarette Smoking an Effect Modifier of the Relation between Antihypertensive Therapy and Blood Lipids?

  1997cites this paper
• Diabetic nephropathy.

  1997cites this paper
• A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects.

  1996cites this paper
• Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension.

  1995cites this paper
• Insulin resistance and hypertension.

  1993cites this paper
• Drug-Induced Disorders of Glucose Tolerance

  1993cites this paper
• [Arterial hypertension and left ventricular dysfunction: pathophysiology, diagnosis and therapy].

  1993cites this paper
• Hypertension and Diabetes: Epidemiologic Aspects as a Guide to Management

  1993cites this paper
• Contrasting Effects of Pyrazinoylguanidine and Hydrochlorothiazide in Patients with Renal Insufficiency

  1993cites this paper
• Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus.

  1993cites this paper
• Angiotensin-converting enzyme inhibitors as cardioprotective agents.

  1992cites this paper
• Isradipine—A Review of Its Antihypertensive and Other Properties

  1992cites this paper
• Diabetes mellitus and raised blood pressure

  1992cites this paper
• [Effect of the captopril-hydrochlorothiazide combination on blood lipids. Study in a population of hypertensive hyperlipidemic patients].

  1992cites this paper
• Metabolic effects of lisinopril versus hydrochlorothiazide plus amiloride in essential hypertension

  1992cites this paper
• Dubbo Study of the elderly: hypertension and lipid levels.

  1992cites this paper
• Hyperinsulinemia, insulin resistance and essential hypertension.

  1992cites this paper
• Crossover trial comparison of enalapril maleate and trichlormethiazide in the treatment of essential hypertension: emphasis on the quality of life.

  1992cites this paper
• [Diuretics and their current role in the treatment of essential arterial hypertension].

  1992cites this paper
• New Antihypertensive Agents: Benefit of Treatment

  1992cites this paper
• Effects of Nifedipine GITS and Atenolol Monotherapy on Serum Lipids, Blood Pressure, Heart Rate, and Weight in Mild to Moderate Hypertension

  1991cites this paper
• Nifedipine vs. Enalapril in Treatment of Hypertensive Patients with Glucose Intolerance

  1991cites this paper
• Cardiovascular risk factors and their interactions in hypertensives.

  1991cites this paper
• Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.

  1991cites this paper
• Insulin Resistance and Hypertension

  1991cites this paper
• Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults.

  1991cites this paper
• [Side effects of long-term drug therapy of patients with uncomplicated arterial hypertension in a polyclinic].

  1991cites this paper
• Choosing the Optimum Therapy for Older Hypertensive Patients

  1991cites this paper
• Hypertension and Coronary Artery Disease Can the Chain Be Broken?

  1991cites this paper
• CAPTOPRIL AND HYDROCHLOROTHIAZIDE—A SAFE ANTIHYPERTENSIVE FOR USE IN GENERAL PRACTICE?

  1991cites this paper
• The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

  1991cites this paper
• Comparative effects of converting enzyme inhibition and conventional therapy in hypertensive non-insulin dependent diabetics with normal renal function.

  1991cites this paper
• Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly.

  1991cites this paper
• Haemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects.

  1991cites this paper
• Drug Treatment of Hypertension in Patients With Diabetes Mellitus

  1991cites this paper
• Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.

  1991cites this paper
• The heart in hypertension and arrhythmias.

  1990cites this paper
• Metabolic Effects of Various Antihypertensive Agents

  1990cites this paper
• Cardiovascular effects of antihypertensive drugs--involvement in the therapeutic choice.

  1990cites this paper
• Angiotensin converting enzyme inhibition and its impact on cardiovascular disease.

  1990cites this paper
• The metabolic effects of diuretics and other antihypertensive drugs: a perspective as of 1989.

  1990cites this paper
• The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.

  1990cites this paper
• Hypertension and diabetes

  1990cites this paper
• Neue Aspekte der antihypertensiven Therapie bei Diabetes mellitus

  1990cites this paper
• Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.

  1989cites this paper
• Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.

  1989cites this paper
• Systemic hypertension as a treatable risk factor for cerebrovascular disease.

  1989cites this paper
• Smoking Accounts for Adverse Effect of Antihypertensive Medications on Plasma Lipids A Population‐Based Study

  1989cites this paper
• Cardiovascular‐risk reduction: initial diuretic therapy compared with calcium‐antagonist (felodipine) therapy for primary hypertension

  1989cites this paper
• ACE inhibitors in hypertension: a US perspective.

  1989cites this paper
• Lipids and hypertension.

  1989cites this paper
• New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension.

  1989cites this paper
• Coronary morbidity and mortality, pre-existing silent coronary artery disease, and mild hypertension.

  1989cites this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  1989cites this paper
• The effects of antihypertensive agents on serum lipids and lipoproteins.

  1988cites this paper
• Cardiovascular and Renal Actions of Calcium Channel Blocker Chemical Subgroups: a Search for Renal Specificity

  1988cites this paper
• Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.

  1988cites this paper
• Pseudo‐Bartter's syndrome, diuretic abuse, idiopathic edema, and eating disorders

  1988cites this paper
• Efficacy of captopril in hypertensive diabetic patients.

  1988cites this paper
• The atherogenic risk of antihypertensive therapy.

  1988cites this paper
• Metabolic side effects induced by diuretic therapy: problems and possible solutions.

  1988cites this paper
• Issues with Antihypertensive Therapy: Safety Perspectives

  1988cites this paper
• The atherogenic risk of antihypertensive therapy

  1988cites this paper
• Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.

  1988cites this paper
• Labetalol in the treatment of elderly patients with mild essential hypertension.

  1988cites this paper
• The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics.

  1988cites this paper
• Comparison of sustained release verapamil and hydrochlorothiazide in hypertension--effect on blood pressure and metabolic variables.

  1987cites this paper
• Serum lipids and lipoproteins in ischaemic heart disease following withdrawal of long-term metoprolol treatment.

  1987cites this paper
• Comparison of enalapril and bendrofluazide for treatment of systemic hypertension.

  1987cites this paper
• Captopril Protects Against Metabolic Effects of Chronic Hydrochlorothiazide Therapy

  1987cites this paper
• Achieving therapeutic goals in insulin-using diabetic patients with non-insulin-dependent diabetes mellitus. A weight reduction-exercise-oral agent approach.

  1987cites this paper
• Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension. A multicenter study.

  1987cites this paper
• Hypertension and Atherosclerosis: Effects of Antihypertensive Drugs on Arterial Flow Patterns

  1987cites this paper